Heartland Home Health Care And Hospice 1426 Straits Drive, Bay City, MI, 48706 | |
(989) 892-0355 |
News Archive
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that for fiscal 2011, the Company expects revenue to be in the range of $71 to $82 million, net profit to be $27 to $31 million and earnings per share to be $0.97 to $1.12, based upon 28 million shares outstanding.
Costs for a lifetime of support for each individual with autism spectrum disorder may reach $2.4 million, according to a new study from researchers from the Perelman School of Medicine at the University of Pennsylvania and the Children's Hospital of Philadelphia.
Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.
A new study has found that factors, such as birth weight, gestational age at birth and lung function, growth and other measures at 8 years, can be used to predict lung function during mid to late teenage years.
Lucideon, the international materials technology company, has published a new white paper titled ‘Hip and Knee Wear Testing – What The Standards Don't Tell You'.
› Verified 6 days ago
Name | Heartland Home Health Care And Hospice |
---|---|
Location | 1426 Straits Drive, Bay City, Michigan |
Hospice ID | 231550 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Other |
Profit Type | FOR PROFIT |
SSA county code | 080 |
News Archive
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that for fiscal 2011, the Company expects revenue to be in the range of $71 to $82 million, net profit to be $27 to $31 million and earnings per share to be $0.97 to $1.12, based upon 28 million shares outstanding.
Costs for a lifetime of support for each individual with autism spectrum disorder may reach $2.4 million, according to a new study from researchers from the Perelman School of Medicine at the University of Pennsylvania and the Children's Hospital of Philadelphia.
Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.
A new study has found that factors, such as birth weight, gestational age at birth and lung function, growth and other measures at 8 years, can be used to predict lung function during mid to late teenage years.
Lucideon, the international materials technology company, has published a new white paper titled ‘Hip and Knee Wear Testing – What The Standards Don't Tell You'.
› Verified 6 days ago
NPI Number | 1760435796 |
Organization Name | Heartland Hospice Services Llc |
Address | 1426 Straits Dr Bay City, Michigan, 48706 |
Phone Number | (989)667-3440 |
News Archive
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that for fiscal 2011, the Company expects revenue to be in the range of $71 to $82 million, net profit to be $27 to $31 million and earnings per share to be $0.97 to $1.12, based upon 28 million shares outstanding.
Costs for a lifetime of support for each individual with autism spectrum disorder may reach $2.4 million, according to a new study from researchers from the Perelman School of Medicine at the University of Pennsylvania and the Children's Hospital of Philadelphia.
Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.
A new study has found that factors, such as birth weight, gestational age at birth and lung function, growth and other measures at 8 years, can be used to predict lung function during mid to late teenage years.
Lucideon, the international materials technology company, has published a new white paper titled ‘Hip and Knee Wear Testing – What The Standards Don't Tell You'.
› Verified 6 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 98.4 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 98.1 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 98.6 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 84.2 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 99.5 | 97.3 |
Patients who got timely treatment for shortness of breath | 96.9 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 97.2 | 93.3 |
News Archive
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that for fiscal 2011, the Company expects revenue to be in the range of $71 to $82 million, net profit to be $27 to $31 million and earnings per share to be $0.97 to $1.12, based upon 28 million shares outstanding.
Costs for a lifetime of support for each individual with autism spectrum disorder may reach $2.4 million, according to a new study from researchers from the Perelman School of Medicine at the University of Pennsylvania and the Children's Hospital of Philadelphia.
Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.
A new study has found that factors, such as birth weight, gestational age at birth and lung function, growth and other measures at 8 years, can be used to predict lung function during mid to late teenage years.
Lucideon, the international materials technology company, has published a new white paper titled ‘Hip and Knee Wear Testing – What The Standards Don't Tell You'.
› Verified 6 days ago
Home Health Aides | 11.5 |
Counselors | 3.7 |
Licensed Practical or Vocational Nurses | 2.8 |
Medical Social Workers | 4.7 |
Physicians | 1 |
Registered Nurses | 15.2 |
Other Personnel | 18 |
Total Employees | 56.9 |
---|
News Archive
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that for fiscal 2011, the Company expects revenue to be in the range of $71 to $82 million, net profit to be $27 to $31 million and earnings per share to be $0.97 to $1.12, based upon 28 million shares outstanding.
Costs for a lifetime of support for each individual with autism spectrum disorder may reach $2.4 million, according to a new study from researchers from the Perelman School of Medicine at the University of Pennsylvania and the Children's Hospital of Philadelphia.
Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.
A new study has found that factors, such as birth weight, gestational age at birth and lung function, growth and other measures at 8 years, can be used to predict lung function during mid to late teenage years.
Lucideon, the international materials technology company, has published a new white paper titled ‘Hip and Knee Wear Testing – What The Standards Don't Tell You'.
› Verified 6 days ago
Others | 4.8 |
Total Volunteers | 4.8 |
---|
News Archive
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that for fiscal 2011, the Company expects revenue to be in the range of $71 to $82 million, net profit to be $27 to $31 million and earnings per share to be $0.97 to $1.12, based upon 28 million shares outstanding.
Costs for a lifetime of support for each individual with autism spectrum disorder may reach $2.4 million, according to a new study from researchers from the Perelman School of Medicine at the University of Pennsylvania and the Children's Hospital of Philadelphia.
Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.
A new study has found that factors, such as birth weight, gestational age at birth and lung function, growth and other measures at 8 years, can be used to predict lung function during mid to late teenage years.
Lucideon, the international materials technology company, has published a new white paper titled ‘Hip and Knee Wear Testing – What The Standards Don't Tell You'.
› Verified 6 days ago
Heartland Home Health Care And Hospice Location: 1426 Straits Drive, Bay City, Michigan, 48706 Phone: (989) 892-0355 |
Compassus - Bay City Location: 401 Center Avenue, Suite 130, Bay City, Michigan, 48708 Phone: (989) 892-0355 |